FC
ADMA icon

FORA Capital’s ADMA Biologics ADMA Stock Holding History

FORA Capital’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,279
Closed -$541K – 483
2025
Q1 		$541K Buy
+27,279
New +$472K 0.05% 318
2024
Q4 		– Sell
-41,547
Closed -$831K – 374
2024
Q3 		$831K Buy
+41,547
New +$646K 0.1% 227

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

FORA Capital's ADMA Position: Q2 2025 in Review

FORA Capital sold out of ADMA Biologics (ADMA) in Q2 2025, closing a stake of 27,279 shares — an estimated $541K sold.

FORA Capital first reported a position in ADMA in Q3 2024 and held it in 2 quarters. The position peaked at $831K in Q3 2024. 368 funds tracked by Wall St. Rank hold ADMA as of Q2 2025.

  • FORA Capital reported no remaining ADMA Biologics position as of Q2 2025 after selling out during the quarter.
  • FORA Capital sold 27,279 ADMA Biologics shares in Q2 2025, an estimated $541K.
  • FORA Capital first reported a position in ADMA Biologics in Q3 2024 and held it in 2 quarters.
  • FORA Capital's ADMA Biologics position peaked at $831K in Q3 2024.
  • 368 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2025.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.